TTM
$3.55
YoY change
+8.0%
5Y CAGR
+21.2%
Peak year (2025)
$7.28
Latest annual
$7.28
EPS (Diluted) history chart for Merck & Co. (MRK) from 1985 to 2025
Latest: $7.28
EPS (Diluted) growth chart for Merck & Co. (MRK) from 1985 to 2025
Latest: +8.0%
EPS (Diluted) history table for Merck & Co. (MRK) from 1985 to 2025
| 2025 | $7.28 | +8.0% | +$0.54 | ||
| 2024 | $6.74 | +4714.3% | +$6.60 | ||
| 2023 | $0.14 | -97.5% | −$5.57 | ||
| 2022 | $5.71 | +11.1% | +$0.57 | ||
| 2021 | $5.14 | +84.9% | +$2.36 | ||
| 2020 | $2.78 | -27.2% | −$1.04 | ||
| 2019 | $3.82 | +64.7% | +$1.50 | ||
| 2018 | $2.32 | +149.5% | +$1.39 | ||
| 2017 | $0.93 | -54.4% | −$1.11 | ||
| 2016 | $2.04 | +30.8% | +$0.48 | ||
| 2015 | $1.56 | -61.7% | −$2.51 | ||
| 2014 | $4.07 | +176.9% | +$2.60 | ||
| 2013 | $1.47 | -31.9% | −$0.69 | ||
| 2012 | $2.16 | +6.9% | +$0.14 | ||
| 2011 | $2.02 | +621.4% | +$1.74 | ||
| 2010 | $0.28 | -93.3% | −$3.87 | ||
| 2009 | $4.15 | +14.3% | +$0.52 | ||
| 2008 | $3.63 | -449.0% | +$4.67 | ||
| 2007 | −$1.04 | -151.2% | −$3.07 | ||
| 2006 | $2.03 | -3.3% | −$0.07 | ||
| 2005 | $2.10 | -19.8% | −$0.52 | ||
| 2004 | $2.62 | -11.8% | −$0.35 | ||
| 2003 | $2.97 | -5.4% | −$0.17 | ||
| 2002 | $3.14 | 0.0% | $0.00 | ||
| 2001 | $3.14 | +8.3% | +$0.24 | ||
| 2000 | $2.90 | +18.4% | +$0.45 | ||
| 1999 | $2.45 | +14.0% | +$0.30 | ||
| 1998 | $2.15 | +15.0% | +$0.28 | ||
| 1997 | $1.87 | +19.9% | +$0.31 | ||
| 1996 | $1.56 | +18.2% | +$0.24 | ||
| 1995 | $1.32 | +11.9% | +$0.14 | ||
| 1994 | $1.18 | +26.9% | +$0.25 | ||
| 1993 | $0.93 | -11.4% | −$0.12 | ||
| 1992 | $1.05 | +15.4% | +$0.14 | ||
| 1991 | $0.91 | +19.7% | +$0.15 | ||
| 1990 | $0.76 | +20.6% | +$0.13 | ||
| 1989 | $0.63 | +23.5% | +$0.12 | ||
| 1988 | $0.51 | +37.8% | +$0.14 | ||
| 1987 | $0.37 | +37.0% | +$0.10 | ||
| 1986 | $0.27 | +28.6% | +$0.06 | ||
| 1985 | $0.21 | — | — |
- 2025$7.28+8.0%
- 2024$6.74+4714.3%
- 2023$0.14-97.5%
- 2022$5.71+11.1%
- 2021$5.14+84.9%
- 2020$2.78-27.2%
- 2019$3.82+64.7%
- 2018$2.32+149.5%
- 2017$0.93-54.4%
- 2016$2.04+30.8%
- 2015$1.56-61.7%
- 2014$4.07+176.9%
- 2013$1.47-31.9%
- 2012$2.16+6.9%
- 2011$2.02+621.4%
- 2010$0.28-93.3%
- 2009$4.15+14.3%
- 2008$3.63-449.0%
- 2007−$1.04-151.2%
- 2006$2.03-3.3%
- 2005$2.10-19.8%
- 2004$2.62-11.8%
- 2003$2.97-5.4%
- 2002$3.140.0%
- 2001$3.14+8.3%
- 2000$2.90+18.4%
- 1999$2.45+14.0%
- 1998$2.15+15.0%
- 1997$1.87+19.9%
- 1996$1.56+18.2%
- 1995$1.32+11.9%
- 1994$1.18+26.9%
- 1993$0.93-11.4%
- 1992$1.05+15.4%
- 1991$0.91+19.7%
- 1990$0.76+20.6%
- 1989$0.63+23.5%
- 1988$0.51+37.8%
- 1987$0.37+37.0%
- 1986$0.27+28.6%
- 1985$0.21—
EPS (Diluted) values are taken from Merck & Co.'s reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EPS (Diluted) at Merck & Co. (MRK)
According to Merck & Co.'s latest reported financial statements, the company's current diluted EPS (TTM) is $3.55. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
In 2025, Merck & Co. (MRK) diluted EPS totalled $7.28 – grew 8.0% year-over-year.
Over 2020–2025 (5 years), Merck & Co. diluted EPS expanded at a +21.2% compound annual rate, sustaining 2 straight years of year-over-year growth.
The highest annual diluted EPS of $7.28 was reported in 2025. The lowest in the available history was −$1.04 in 2007.
Merck & Co. EPS (Diluted) by Year
Merck & Co. EPS (Diluted) 2025: $7.28
2025's diluted EPS for Merck & Co. came in at $7.28, grew 8.0% from 2024. This figure represents the highest annual value in the available history.
Merck & Co. EPS (Diluted) 2024: $6.74
Merck & Co. posted diluted EPS of $6.74 in 2024, surged 4714.3% from 2023.
Merck & Co. EPS (Diluted) 2023: $0.14
In 2023, Merck & Co. reported diluted EPS of $0.14, plunged 97.5% below 2022.
Merck & Co. EPS (Diluted) 2022: $5.71
Merck & Co. diluted EPS in 2022 was $5.71, grew 11.1% from 2021.
Merck & Co. EPS (Diluted) 2021: $5.14
Merck & Co. diluted EPS in 2021 was $5.14.
See more financial history for Merck & Co. (MRK). Or calculate EPS yourself.
Sector peers by EPS (Diluted)
Healthcare peers of Merck & Co. (MRK), ranked by their latest diluted EPS
| $22.95 | |
| $17.74 | |
| $14.23 | |
| $13.23 | |
| $11.03 | |
| $6.54 | |
| $3.59 | |
| $2.37 |
- $22.95
- $14.23
- $13.23
- $11.03
- $6.54
- $3.59
- $2.37
Frequently asked questions
Merck & Co. (MRK) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation